This is experimental AI integration by Kagi Search. It is currently offered as free research preview and will be soon integrated into Kagi.
Antiphospholipid syndrome (APS), also known as Hughes syndrome, is a disorder of the immune system that causes an increased risk of blood clots [1]. It is caused by the body's immune system producing abnormal antibodies called antiphospholipid antibodies [3]. Symptoms include thrombosis and/or an adverse pregnancy outcome in the presence of antiphospholipid antibodies [7]. It is mostly present in young women [2] and can be diagnosed using criteria outlined in the Sapporo preliminary classification criteria for APS or at the Eleventh International Congress on antiphospholipid antibodies [8]. Treatment includes medications to reduce clotting risk such as aspirin, heparin, warfarin, and other drugs to suppress inflammation or modify immunity[4][5][6].
[1]: Antiphospholipid syndrome (APS) - NHS (https://www.nhs.uk/conditions/antiphospholipid-syndrome/) [2]: Antiphospholipid Syndrome (https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Diseases-Conditions/Antiphospholipid-Syndrome) [3]: Antiphospholipid syndrome (APS) - Causes - NHS (https://www.nhs.uk/conditions/antiphospholipid-syndrome/causes/) [4]: Antiphospholipid Syndrome: Symptoms, Diagnosis & Treatment (https://my.clevelandclinic.org/health/diseases/21685-antiphospholipid-syndrome) [5]: Antiphospholipid Syndrome - National Organization for Rare Disorders (https://rarediseases.org/rare-diseases/antiphospholipid-syndrome/) [6]: Antiphospholipid syndrome: MedlinePlus Genetics (https://medlineplus.gov/genetics/condition/antiphospholipid-syndrome/) [7]: Diagnosis of antiphospholipid syndrome - UpToDate (https://www.uptodate.com/contents/diagnosis-of-antiphospholipid-syndrome) [8]: International consensus statement on an update of the classification ... (https://pubmed.ncbi.nlm.nih.gov/16420554/)
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies in the blood. These antibodies can cause a variety of symptoms, including recurrent miscarriages, thrombosis, and stroke. Treatment typically involves anticoagulant medications to reduce the risk of clotting and other complications.